ITRM vs WAT · rev $390.0K vs P/E 32, rev $1.65B
Iterum Therapeutics PLC (ITRM) versus Waters Corporation (WAT) — a side-by-side from cached financials, not a winner call.
Iterum Therapeutics PLC (ITRM) is a biotechnology company listed on US.
Waters Corporation (WAT) is a diagnostics & research company listed on US.
Latest reported ITRM revenue for 2025-09-30 was $390.0K. Net income was -$20.4M. ITRM currently screens at market cap $38.6M.
Latest reported WAT revenue for 2026-07-04 was $1.65B. Net income was -$136.0M. Revenue was up 29.8% from 2026-04-04 to 2026-07-04. WAT currently screens at market cap $20.84B and trailing P/E 31.8.
ITRM currently screens at market cap $38.6M. WAT currently screens at market cap $20.84B and trailing P/E 31.8.
Not investment advice. Open the ITRM and WAT stock pages for the full models.
Not investment advice.